UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 438

Sortiert nach

Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas

Journal of clinical oncology, 2018-01, Vol.36 (2), p.168-179

2018

Link zum Volltext

Verfügbarkeit prüfen

Germline Mutations in Predisposition Genes in Pediatric Cancer

The New England journal of medicine, 2015-12, Vol.373 (24), p.2336-2346

2015

Link zum Volltext

Verfügbarkeit prüfen

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4541-4547

2011

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3844-3851

2006

Link zum Volltext

Verfügbarkeit prüfen

Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous

Acta neuropathologica, 2018-08, Vol.136 (2), p.315-326

2018

Link zum Volltext

Verfügbarkeit prüfen

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic

Journal of clinical oncology, 2017-02, Vol.35 (5), p.523-528

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors

Pediatric blood & cancer, 2023-10, Vol.70 (10), p.e30437-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Germline genomic findings in children and young adults with melanocytic tumors

Pediatric blood & cancer, 2023-07, Vol.70 (7), p.e30361-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

International journal of cancer, 2017-10, Vol.141 (7), p.1469-1477

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007

Journal of clinical oncology, 2012-06, Vol.30 (16), p.2005-2012

2012

Link zum Volltext

Verfügbarkeit prüfen

Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With Vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group

Journal of clinical oncology, 2007-02, Vol.25 (4), p.362-369

2007

Link zum Volltext

Verfügbarkeit prüfen

Infrequent Tumor Initiative of the Children's Oncology Group: Initial Lessons Learned and Their Impact on Future Plans

Journal of clinical oncology, 2010-11, Vol.28 (33), p.5011-5016

2010

Link zum Volltext

Verfügbarkeit prüfen

Pediatric gastrointestinal stromal tumors

Hematology/oncology clinics of North America, 2009-02, Vol.23 (1), p.15

2009

Link zum Volltext

Verfügbarkeit prüfen

Ocular Manifestations of Hypoxia-Inducible Factor-2α Paraganglioma-Somatostatinoma-Polycythemia Syndrome

Ophthalmology (Rochester, Minn.), 2014-11, Vol.121 (11), p.2291-2293

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

Journal of clinical oncology, 2003-01, Vol.21 (1), p.78-84

2003

Link zum Volltext

Verfügbarkeit prüfen

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

The lancet oncology, 2018-05, Vol.19 (5), p.705-714

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000176

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic Predisposition to Neonatal Tumors

Current pediatric reviews, 2015-01, Vol.11 (3), p.164

2015

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review

Sarcoma, 2015, Vol.2015, p.608279-6

2015

Link zum Volltext

Verfügbarkeit prüfen

Top advances of the year: Pediatric oncology

Cancer, 2022-10, Vol.128 (20), p.3593-3596

2022

Link zum Volltext

Verfügbarkeit prüfen

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas

Cancer, 2018-11, Vol.124 (21), p.4241-4247

2018

Link zum Volltext

Verfügbarkeit prüfen

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

Clinical cancer research, 2017-11, Vol.23 (21), p.6441-6449

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study

Journal of clinical oncology, 2019-12, Vol.37 (35), p.3369-3376

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 438

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(401)

Publikationsform

Sprache

Englisch
(438)
Japanisch
(50)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(277)
Humans
(274)
Life Sciences & Biomedicine
(270)
Child
(220)
Oncology
(212)
Female
(179)
Adolescent
(178)
Male
(172)
Child, Preschool
(137)
Pediatrics
(132)
Biological And Medical Sciences
(118)
Medical Sciences
(117)
Adult
(100)
Infant
(92)
Tumors
(71)
Retrospective Studies
(60)
Hematology
(54)
Treatment Outcome
(54)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(51)
Prognosis
(51)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas

Germline Mutations in Predisposition Genes in Pediatric Cancer

A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic

Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors

Germline genomic findings in children and young adults with melanocytic tumors

A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007

Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With Vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group

Infrequent Tumor Initiative of the Children's Oncology Group: Initial Lessons Learned and Their Impact on Future Plans

Pediatric gastrointestinal stromal tumors

Ocular Manifestations of Hypoxia-Inducible Factor-2α Paraganglioma-Somatostatinoma-Polycythemia Syndrome

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

Genetic Predisposition to Neonatal Tumors

Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective Review

Top advances of the year: Pediatric oncology

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma

Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study

Suchergebnisse filtern